Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal interventions.

Insulin enhances the effect of nitric oxide at inhibiting neointimal hyperplasia in a rat model of type 1 diabetes. Am J Physiol Heart Circ Physiol (2010) 0.95

Predictors of failure and success of tibial interventions for critical limb ischemia. J Vasc Surg (2010) 0.94

Effect of metabolic syndrome on the response to arterial injury. J Surg Res (2014) 0.83

Clinical outcomes after endovascular treatment of superficial femoral disease in patients with disabling claudication and critical limb ischemia: midterm analysis. Angiology (2011) 0.79

Neo-intimal hyperplasia, diabetes and endovascular injury. Cardiovasc J Afr (2012) 0.77

Efficacy of endoluminal interventional therapy in diabetic peripheral arterial occlusive disease: a retrospective trial. Cardiovasc Diabetol (2012) 0.77

Management of critical lower limb ischemia in endovascular era: experience from 511 patients. Int J Angiol (2014) 0.75

Impact of Chronic Kidney Disease on Clinical Outcomes of Endovascular Treatment for Femoropopliteal Arterial Disease. J Vasc Interv Radiol (2016) 0.75

Retrospective review of superficial femoral artery stenting in diabetic patients: thiazolidinedione use may decrease reinterventions. BMC Cardiovasc Disord (2014) 0.75

Regarding "Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal interventions". J Vasc Surg (2008) 0.75

Dorsomorphin homologue 1, a highly selective small-molecule bone morphogenetic protein inhibitor, suppresses medial artery calcification. J Vasc Surg (2016) 0.75

Think Before Chopping a Diabetic Foot: Insight to Vascular Intervention. Cureus (2017) 0.75

Pseudoaneurysms and the role of minimally invasive techniques in their management. Radiographics (2005) 3.76

Percutaneous angioplasty and stenting of the superficial femoral artery. J Vasc Surg (2005) 1.77

Hemodynamic benefits of regional anesthesia for carotid endarterectomy. J Vasc Surg (2002) 1.61

Influence of chronic renal insufficiency on outcomes following carotid revascularization. Arch Surg (2011) 1.53

Catheter thrombolysis of thrombosed hepatic arteries in liver transplant recipients: predictors of success and role of thrombolysis. Vasc Endovascular Surg (2007) 1.47

Characterizing cardiopulmonary arrest during interventional radiology procedures. J Vasc Interv Radiol (2013) 1.45

Current efficacy of open and endovascular interventions for advanced superficial femoral artery occlusive disease. J Vasc Surg (2013) 1.43

Arc of buhler: incidence and diameter in asymptomatic individuals. Vasc Endovascular Surg (2005) 1.42

Outcomes of patients with acute upper gastrointestinal nonvariceal hemorrhage referred to interventional radiology for potential embolotherapy. J Clin Gastroenterol (2014) 1.38

Endovascular therapy as the primary approach for limb salvage in patients with critical limb ischemia: experience with 443 infrapopliteal procedures. Vascular (2006) 1.25

Vascular biology of metabolic syndrome. J Vasc Surg (2011) 1.21

Implications of in situ thrombosis and distal embolization during superficial femoral artery endoluminal intervention. Ann Vasc Surg (2009) 1.11

Skeletal muscle BOLD MRI: from underlying physiological concepts to its usefulness in clinical conditions. J Magn Reson Imaging (2012) 1.10

Real-time sonoelastography of hepatic thermal lesions in a swine model. Med Phys (2008) 1.10

The long-term outcomes of percutaneous therapy for renal artery fibromuscular dysplasia. J Vasc Surg (2008) 1.08

Domain-dependent action of urokinase on smooth muscle cell responses. J Vasc Surg (2004) 1.08

Rotational muscle flap closure for acute groin wound infections following vascular surgery. Ann Vasc Surg (2004) 1.06

Long-term outcomes of catheter directed thrombolysis for lower extremity deep venous thrombosis without prophylactic inferior vena cava filter placement. J Vasc Surg (2007) 1.02

Plasminogen activator system and vascular disease. Curr Vasc Pharmacol (2006) 1.02

Experience with endovascular abdominal aortic aneurysm repair in nonagenarians. J Endovasc Ther (2006) 1.02

Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor. J Vasc Surg (2005) 1.02

Predictors of early mortality after transjugular intrahepatic portosystemic shunt creation for the treatment of refractory ascites. J Vasc Interv Radiol (2006) 1.01

Balloon-occlusion catheter rupture during balloon-occluded retrograde transvenous obliteration of gastric varices utilizing sodium tetradecyl sulfate: incidence and consequences. Vasc Endovascular Surg (2012) 1.01

Sphingosine-1-phosphate-induced smooth muscle cell migration involves the mammalian target of rapamycin. J Vasc Surg (2005) 1.01

Flow-induced neointimal regression in baboon polytetrafluoroethylene grafts is associated with decreased cell proliferation and increased apoptosis. J Vasc Surg (2002) 1.00

Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients. J Vasc Surg (2007) 0.99

Influence of LVAD cannula outflow tract location on hemodynamics in the ascending aorta: a patient-specific computational fluid dynamics approach. ASAIO J (2012) 0.97

Percutaneous transluminal revascularization for iliac occlusive disease: long-term outcomes in TransAtlantic Inter-Society Consensus A and B lesions. Ann Vasc Surg (2005) 0.96

Management of effort thrombosis of the subclavian vein: today's treatment. Ann Vasc Surg (2007) 0.94

Increased plasmin and serine proteinase activity during flow-induced intimal atrophy in baboon PTFE grafts. Arterioscler Thromb Vasc Biol (2002) 0.94

Hybrid thoracic endovascular aortic repair: pushing the envelope. J Vasc Surg (2009) 0.94

Endovascular treatment of complicated aortic aneurysms in patients with underlying arteriopathies. Ann Vasc Surg (2006) 0.94

Sphingosine-1-phosphate induces G(alphai)-coupled, PI3K/ras-dependent smooth muscle cell migration. J Surg Res (2002) 0.93

Impact of runoff on superficial femoral artery endoluminal interventions for rest pain and tissue loss. J Vasc Surg (2008) 0.93

Radiation arteritis: a contraindication to carotid stenting? J Vasc Surg (2007) 0.92

Efficacy of covered stent placement for central venous occlusive disease in hemodialysis patients. J Vasc Surg (2011) 0.92

Urokinase-induced smooth muscle cell migration requires PI3-K and Akt activation. J Surg Res (2005) 0.92

Outcome after autogenous brachial-basilic upper arm transpositions in the post-National Kidney Foundation Dialysis Outcomes Quality Initiative era. J Vasc Surg (2005) 0.91

Endovascular thoracic aortic repair and previous or concomitant abdominal aortic repair: is the increased risk of spinal cord ischemia real? Ann Vasc Surg (2006) 0.90

Prevalence of variant brachial-basilic vein anatomy and implications for vascular access planning. J Vasc Surg (2010) 0.90

Long-term outcomes of endoluminal therapy for chronic atherosclerotic occlusive mesenteric disease. Ann Vasc Surg (2008) 0.90

Protective value of TIPS against the development of hydrothorax/ascites and upper gastrointestinal bleeding after balloon-occluded retrograde transvenous obliteration (BRTO). Am J Gastroenterol (2013) 0.90

Sphingosine-1-phosphate stimulates smooth muscle cell migration through galpha(i)- and pi3-kinase-dependent p38(MAPK) activation. J Surg Res (2003) 0.90

Feasibility of simultaneous pre- and postfilter transcranial Doppler monitoring during carotid artery stenting. J Vasc Surg (2009) 0.90

Is there a selection bias in applying endovascular aneurysm repair for rupture? Ann Vasc Surg (2008) 0.90

Management of bleeding after percutaneous transhepatic cholangiography or transhepatic biliary drain placement. Tech Vasc Interv Radiol (2008) 0.90

Hepatic artery stenosis in liver transplant recipients: primary treatment with percutaneous transluminal angioplasty. J Vasc Interv Radiol (2005) 0.90

Computational hemodynamics in the human aorta: a computational fluid dynamics study of three cases with patient-specific geometries and inflow rates. Technol Health Care (2008) 0.89

Metabolic syndrome: A predictor of adverse outcomes after carotid revascularization. J Vasc Surg (2009) 0.89

Hemodynamics of distal revascularization-interval ligation. Ann Vasc Surg (2005) 0.89

Patterns of kinase activation induced by injury in the murine femoral artery. J Surg Res (2007) 0.89

Impact of metabolic syndrome on the outcomes of percutaneous renal angioplasty and stenting. J Vasc Surg (2010) 0.89

Medical and endovascular management of critical limb ischemia. J Endovasc Ther (2009) 0.89

Blood oxygenation level-dependent (BOLD) MRI of human skeletal muscle at 1.5 and 3 T. J Magn Reson Imaging (2012) 0.88

Hybrid debranching-endovascular repair of visceral patch aneurysm after thoracoabdominal aneurysm repair. Vasc Endovascular Surg (2007) 0.88

Percutaneous superficial femoral artery interventions for claudication--does runoff matter? Ann Vasc Surg (2008) 0.88

Differential regulation of ERK1/2 and p38(MAPK) by components of the Rho signaling pathway during sphingosine-1-phosphate-induced smooth muscle cell migration. J Surg Res (2004) 0.88

Use of computer simulation for determining endovascular skill levels in a carotid stenting model. J Vasc Surg (2004) 0.88

Longitudinal computational fluid dynamics study of aneurysmal dilatation in a chronic DeBakey type III aortic dissection. J Vasc Surg (2012) 0.88

Management of vascular and nonvascular complications after renal transplantation. Tech Vasc Interv Radiol (2009) 0.87

Sphingosine-1-phosphate-induced oxygen free radical generation in smooth muscle cell migration requires Galpha12/13 protein-mediated phospholipase C activation. J Vasc Surg (2007) 0.87

Patterns of gelatinase activation induced by injury in the murine femoral artery. J Surg Res (2008) 0.87

Hybrid thoracic endovascular aortic repair via right anterior minithoracotomy. J Thorac Cardiovasc Surg (2011) 0.86

Impact of tear location on hemodynamics in a type B aortic dissection investigated with computational fluid dynamics. Conf Proc IEEE Eng Med Biol Soc (2010) 0.86

Cell migration in response to the amino-terminal fragment of urokinase requires epidermal growth factor receptor activation through an ADAM-mediated mechanism. J Vasc Surg (2009) 0.86

Stent-grafts for transjugular intrahepatic portosystemic shunt creation: specialized TIPS stent-graft versus generic stent-graft/bare stent combination. J Vasc Interv Radiol (2010) 0.86

Transhepatic hemodialysis catheters: functional outcome and comparison between early and late failure. J Vasc Interv Radiol (2011) 0.86

Implications of early failure of superficial femoral artery endoluminal interventions. Ann Vasc Surg (2005) 0.85

Spontaneous regression of an abdominal aortic aneurysm in an immunocompromised patient. Vasc Med (2010) 0.85

Endoluminal management of arterioportal fistulae in liver transplant recipients: a single-center experience. Vasc Endovascular Surg (2007) 0.84

Inadvertent discontinuation of percutaneous nephrostomy catheters in adult native kidneys: incidence and percutaneous management. J Vasc Interv Radiol (2006) 0.84

Concomitant reconstruction of infrarenal aorta and inferior vena cava after en bloc resection of retroperitoneal rhabdomyosarcoma. Vasc Endovascular Surg (2011) 0.84

Increasing dialysis access options in lower extremity: retroperitoneal approach for external iliac artery-vein arteriovenous graft. J Vasc Access (2011) 0.84

Evolving strategies for the treatment of aortoenteric fistulas. J Vasc Surg (2006) 0.84

Endovascular management of central venous stenoses in the hemodialysis patient: results of percutaneous therapy. Vasc Endovascular Surg (2004) 0.84

A computational fluid dynamics study pre- and post-stent graft placement in an acute type B aortic dissection. Vasc Endovascular Surg (2010) 0.84

Plasmin induces smooth muscle cell proliferation. J Surg Res (2005) 0.84

Balloon-occluded retrograde transvenous obliteration of gastric varices. AJR Am J Roentgenol (2012) 0.84

Subclavian artery revascularization: an outcome analysis based on mode of therapy and presenting symptoms. Ann Vasc Surg (2008) 0.83

Transjugular intrahepatic portosystemic shunts in liver transplant recipients: technical analysis and clinical outcome. AJR Am J Roentgenol (2013) 0.83

Percutaneous therapy for renal artery fibromuscular dysplasia. Ann Vasc Surg (2003) 0.83

Transhepatic dilation of anastomotic biliary strictures in liver transplant recipients with use of a combined cutting and conventional balloon protocol: technical safety and efficacy. J Vasc Interv Radiol (2006) 0.83

Regional quality groups in the Society for Vascular Surgery® Vascular Quality Initiative. J Vasc Surg (2013) 0.83

Extrahepatic pseudoaneurysms and ruptures of the hepatic artery in liver transplant recipients: endovascular management and a new iatrogenic etiology. Cardiovasc Intervent Radiol (2012) 0.83